Literature DB >> 29542115

Painful musculosceletal disorders and depression among working aged migraineurs.

M-L Sumelahti1,2, K Mattila1, M Sumanen1.   

Abstract

OBJECTIVE: Musculoskeletal disorders and depression are common among migraineurs. The aim of our study was to evaluate the occurrence of these disorders among working aged migraineurs.
MATERIAL AND METHODS: The risk for fibromyalgia, rheumatoid arthritis (RA), osteoarthrosis (OA), sciatic syndrome, and the occurrence of depression was studied among cases who reported about these conditions and migraine in working aged Finnish population in The Health and Social Support Study (HeSSup) based on postal questionnaire in 2012. Group differences were tested by chi-square test. Odds ratios (ORs with 95% CI) adjusted for age, gender, education level and depression were calculated with logistic regression analysis.
RESULTS: Total of 1505 migraineurs (13%) and 8092 controls were included among the 11 596 responders in 2012. Age and gender adjusted ORs, 2.37 (95% CI 1.81-3.09) for fibromyalgia, 1.46 (1.10-1.95) for RA, 1.58 (1.38-1.80) for OA, and 2.09 (1.84-2.37) for sciatic syndrome, were significant. At least moderate depression was more common among migraineurs (7.3%) than among controls (3.4%) (P < .001).
CONCLUSION: Recognition of comorbid musculoskeletal disorders and mood disorders among migraineurs needs targeted outreach in working aged population. The acute and preventive treatments to control for neuronal sensitization in migraine and comorbid pain disorders may benefit of individual treatment plan and tailored use of antidepressants.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  comorbidity; fibromyalgia; migraine; musculoskeletal disorders

Mesh:

Year:  2018        PMID: 29542115     DOI: 10.1111/ane.12919

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  2 in total

1.  Tolerability of Palmitoylethanolamide in a Pediatric Population Suffering from Migraine: A Pilot Study.

Authors:  Laura Papetti; Giorgia Sforza; Giulia Tullo; Pierfrancesco Alaimo di Loro; Romina Moavero; Fabiana Ursitti; Michela Ada Noris Ferilli; Samuela Tarantino; Federico Vigevano; Massimiliano Valeriani
Journal:  Pain Res Manag       Date:  2020-04-24       Impact factor: 3.037

2.  My Migraine Voice survey: disease impact on healthcare resource utilization, personal and working life in Finland.

Authors:  Marja-Liisa Sumelahti; Markku Sumanen; Merika S Sumanen; Samuli Tuominen; Johanna Vikkula; Sanna M Honkala; Stina Rosqvist; Minna A Korolainen
Journal:  J Headache Pain       Date:  2020-09-29       Impact factor: 7.277

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.